Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 9,478

Document Document Title
WO2006019358A3
The present invention relates to a process for preparing Tamsulosin, an anti-benign prostatic hyperplasia drug, which comprises converting o-ethoxyphenoxyethanol to a corresponding sulfonate, and reacting the sulfonate with (R)-(-)-5-(2-...  
WO/2006/127184A1
The present invention is directed to a process for the preparation of sulphonylimine derivatives [particularly those of formula (XII)] and sulphamide derivatives [particularly those of formula (I)]. The process comprises reacting an alde...  
WO/2006/120816A1
A process in which a functional molecule capable of ionic dissociation which is stable not only chemically but also thermally under operating conditions required for electrochemical apparatus, such as fuel cells, being suitable for use a...  
WO/2006/117662A3
The invention relates to processes for the preparation of polymorphic forms of (R)-(-)- tamsulosin. More particularly, it relates to the preparation of polymorphic forms of (R)-(-)- tamsulosin designated as Form I and II. The invention a...  
WO/2006/117662A2
The invention relates to processes for the preparation of polymorphic forms of (R)-(-)- tamsulosin. More particularly, it relates to the preparation of polymorphic forms of (R)-(-)- tamsulosin designated as Form I and II. The invention a...  
WO/2006/113910A3
The present invention relates to compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion. These compounds can be useful for the prevention and treatment of various diseases, pa...  
WO/2006/109570A1
Disclosed is a method for commercially advantageously producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate with high yield. Specifically disclosed is a method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-but...  
WO/2006/108883A1
The present invention relates to a method for preparing a highly soluble linear alkyl benzene sulphonate (LAS). Specifically, the method includes adding a hydrotropic composition before or after the sulphonation of the linear alkyl benze...  
WO/2006/106800A1
Disclosed is a method for producing a compound (III), a salt thereof or a solvate of them by reacting a compound (I), a salt thereof or a solvate of them with a compound (II) in a toluene solvent in the presence of an additive such as wa...  
WO/2006/106960A1
A disulfonyl fluoride compound is easily and efficiently produced through a coupling reaction. The compound is converted to produce a useful compound. A compound (1) in which Y is fluorine is subjected to a photocoupling reaction, while ...  
WO/2006/106244A3
The invention relates to a method for preparing a compound of formula (I) in which: R1, R2, R3, while being identical or different, are protective groups and Nu is a nucleophilic group, to a method in which a nucleophilic compound is rea...  
WO/2006/106244A2
The invention relates to a method for preparing a compound of formula (I) in which: R1, R2, R3, while being identical or different, are protective groups and Nu is a nucleophilic group, to a method in which a nucleophilic compound is rea...  
WO2005069751A3
Radicals with unpaired electrons are used to initiate a chain reaction that converts small hydrocarbons such as methane into oxygenated liquids. An initiator such as Marshall's acid is used to create methyl radicals. These radicals combi...  
WO/2006/097421A1
The present invention relates to a method of removing SO2 contaminants from dimethyl sulfate (DMS) by treatment with an oxidizing agent, and to a process for the preparation of odour free fatty acid trialkanolamine esters quaternized wit...  
WO/2006/091870A3
α,β-Unsaturated sulfides, sulfones, sulfoxides and sulfonamides according to Formula (I): wherein Ar1, Ar2, X, n, * and R are as defined herein, are prepared by dehydration of β-hydroxy sulfides, sulfones, sulfoxides or sulfonamides.  
WO2006052522A3
Disclosed are methods for making the phosphonium sulfonate salt of generic formula: (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 ...  
WO/2006/087166A1
Provided is a process for the preparation of N-monosubstituted β-aminoalcohol sulfonates of formula (Ia), (Ib) wherein R1 is C6-20 aryl or C4-12 heteroaryl, each optionally being substituted with one or more halogen atoms and/or one or ...  
WO/2006/072259A3
The quantitatively most important pathway for the excretion of cholesterol in mammals is the formation of bile salts (the conjugate bases of bile acids). The major bile salts are synthesized and secreted by as glycine or taurine conjugat...  
WO/2006/072259A2
The quantitatively most important pathway for the excretion of cholesterol in mammals is the formation of bile salts (the conjugate bases of bile acids). The major bile salts are synthesized and secreted by as glycine or taurine conjugat...  
WO2005044795A8
The present invention provides an efficient synthesis for the preparation of ((1R,3S)-3-isopropyl-3- {[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl] carbonyl} cyclopentyl)[(3S,4S)-3-m ethoxytetrahydro- 2H-pyran-4-yl]amine an...  
WO/2006/061549A1
A process for producing tamsulosin of formula (I) and pharmaceutically acceptable addition salts, thereof comprises the steps of : a) Reacting compound R,R-[2-(4-methoxy-phenyl)-1-methyl-ethyl]-(1-phenyl-ethyl)-a mine of formula (II) or ...  
WO/2006/059700A1
Disclosed is a separating agent for asymmetric substances which has high separation performance. Specifically disclosed is a polysulfonamide derivative represented by the following formula (1) or (2). (In the formulae, R represents an op...  
WO/2006/051697A1
Disclosed is a method for producing a fluorine-containing fluorosulfonyl alkylvinyl ether represented by the following chemical formula: CF2=CFOCF2CF2SO2F which is characterized in that a fluorine-containing chlorosulfonyl alkylvinyl eth...  
WO/2006/052522A2
Disclosed are methods for making the phosphonium sulfonate salt of generic formula: (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 ...  
WO2005108441A3
A polymer is provided in which a sulfonic group or a derivative thereof is introduced. The polymer includes a unit represented by the following chemical formula (1): wherein R represents -A1-SO2R1; A1 is selected from an alkylene group, ...  
WO2005123646A3
The production of fluoroorganic compounds in the form of amidoamines, quaternised compounds thereof, amides and ethers, guanidides, hydrazides, ureides, thioureides, perfluoropolyoxaalkylenesulfo- or perfluoropolyoxaalkylenecarboxylic ac...  
WO/2006/042678A1
The invention relates to a method for cleaning 3-hydroxyamidinophenylalanine derivatives comprising the steps: (a) addition of an aromatic sulphonic acid to a solution of an optionally contaminated 3-hydroxyamidinophenylalanine derivativ...  
WO/2006/040131A1
The invention relates to a method for combining carbon-carbon bonds starting from a copper compound of an aryl, heteroaryl, alkene or alkine and an aryl, heteroaryl, alkene or alkine compound with a suitable nucleofuge. The copper compou...  
WO2005081777A3
Severely sterically hindered secondary aminoether alcohols are prepared by reacting an organic carboxylic acid or alkali metal salt of an organic carboxylic acid with a sulfonyl halide, a sulfuryl halide, a mixed sulfuryl ester halide or...  
WO/2006/023611A1
The present invention provides method for making a compound of formula (1) comprising the steps of reacting compounds of formulas (2) and (3) to produce a compound of formula (4) wherein R1, R2, R3, R4 and R5 are defined as described her...  
WO/2006/019358A2
The present invention relates to a process for preparing Tamsulosin, an anti-benign prostatic hyperplasia drug, which comprises converting o-ethoxyphenoxyethanol to a corresponding sulfonate, and reacting the sulfonate with (R)-(-)-5-(2-...  
WO2005118529A3
This invention relates to a process for preparing optically active a -amino acid substrates which are used to make potent lethal factor (LF) inhibitors for the treatment of anthrax. This invention further relates to a process for synthes...  
WO/2006/006156A2
The invention provides methods for detection of medical disorders, associated with cellular oxidative stress, cell degeneration and / or cell death. The invention further relates to compounds comprising a thiol (-SH) group, for detecting...  
WO/2006/004093A1
A process for industrially advantageously producing tamsulosin or a pharmacologically acceptable salt thereof, which are useful as a therapeutic agent for urination disorders accompanying prostatic hypertrophy. The process, which is for ...  
WO/2006/003795A1
A process which comprises using a stable Ru(salen)(CO) complex represented by the general formula (I) or an enantiomer thereof as the catalyst and by which optically active aziridines and amines can be produced enantioselectively with a ...  
WO/2005/123646A2
The production of fluoroorganic compounds in the form of amidoamines, quaternised compounds thereof, amides and ethers, guanidides, hydrazides, ureides, thioureides, perfluoropolyoxaalkylenesulfo- or perfluoropolyoxaalkylenecarboxylic ac...  
WO2005100307A3
A method for making the phosphonium sulfonate salt of generic formula (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 and q and r ar...  
WO/2005/118529A2
This invention relates to a process for preparing optically active &agr -amino acid substrates which are used to make potent lethal factor (LF) inhibitors for the treatment of anthrax. This invention further relates to a process for synt...  
WO/2005/105737A1
The present invention relates to novel processes for the preparation of substituted tetralin and substituted indane derivatives. The present invention is further directed to novel processes for the preparation of intermediates in the pre...  
WO2005049556A3
The subject matter of the invention is a process for the production of metal salts of trifluoromethane sulphonic acid by reacting trifluoromethane sulphonic acid with a metal alcoholate and the use thereof as esterification catalyst and/...  
WO/2005/102993A1
A process for the purification of aqueous acid solutions which can dispense with the step of removing chloride ions and which is reduced in the damage to an ion exchanger (such as an ion-exchange column) and thereby permits repeated use ...  
WO/2005/100307A2
A method for making the phosphonium sulfonate salt of generic formula (1): wherein each X is independently a halogen or hydrogen, provided that the molar ratio of halogen to hydrogen is greater than about 0.90; p is 0 or 1 and q and r ar...  
WO/2005/095323A1
La présente invention concerne un procédé de préparation de composé ester activateur de blanchiment. Ce procédé consiste (A) à préparer un monoester d'acide gras, (B) à fabriquer un chloroformate par réaction de ce monoester d...  
WO/2005/092952A1
A process for sulfating alkoxylated amines, alkoxylated polyols, hydrophobic polyamine ethoxylate polymers, via the use of sulfuric acid.  
WO/2005/085187A1
Disclosed is a method for producing an &ohgr -fluorosulfonyl perfluoroalkyl vinyl ether represented by the general formula (2) below through specific steps (a)-(c) from an &ohgr -haloperfluoroalkyl sulfonyl fluoride represented by the ge...  
WO/2005/081777A2
Severely sterically hindered secondary aminoether alcohols are prepared by reacting an organic carboxylic acid or alkali metal salt of an organic carboxylic acid with a sulfonyl halide, a sulfuryl halide, a mixed sulfuryl ester halide or...  
WO/2005/082843A1
The present invention provides processes for the preparation of arylalkylsulfonyl halides and heteroarylalkylsufonyl halides of Formula: Ar-R-SO2-X, that are useful as intermediates in the preparation of pharmaceuticals.  
WO2004108636A3
A radioisotope labeled reagent includes a compound having the general formula (I) where a in each occurrence independently is a carbon mass number between 11 and 14 inclusive, b in each occurrence independently is a hydrogen mass number ...  
WO2005065164A3
A process for preparing fluorochemical monoisocyanates comprises reacting at least one fluorochemical alcohol represented by the formula CnF2n+1SO2NCH3 (CH2) mOH, wherein n = 2 to 5, and m = 2 to 4, with 4,4' -diphenylmethane diisocyanat...  
WO/2005/080323A1
The invention relates to an improved process for the manufacture of enantiomerically pure R-(+) or S-(+)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide by resolution of (R,S)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide with D-(-) or L...  

Matches 601 - 650 out of 9,478